Search Results 801-810 of 16381 for monoclonal antibody

1. Overview - Department of Immunology - Mayo Clinic Research

   Chronic inflammation; Infections; Tissue transplantation. Two institutional core research resources, the Antibody Hybridoma Core and the Immune Monitoring Core, ...

2. Mayo Clinic Q and A: Different types of COVID-19 tests

   Antibody testing, also called serology testing, determines if someone has been infected in the past. Antibodies are produced by a person's immune system, and ...

3. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Subjects With Warm Autoimmune Hemolytic Anemia (wAIHA) - Mayo Clinic

   - History of splenectomy within the 3 months prior to screening. - Received rituximab or other anti-CD20 monoclonal antibody <3 months prior to screening ...

4. A Study to Evaluate Positive SARS-CoV-2 Antibodies in Subjects with Bipolar Disorder - Mayo Clinic

   The purpose of this study is to evaluate the clinical and neurocognitive correlates of COVID-19 in patients with bipolar disorder (BD). Participation ...

5. Brain Tumor Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as ... Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan.

6. A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD) - Mayo Clinic

   A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease ...

7. A Study of GDC-0199 (ABT-199) Plus MabThera/Rituxan (Rituximab) Compared with Bendamustine Plus MabThera/Rituxan (Rituximab) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

   Received an anti-CLL monoclonal antibody within 8 weeks prior to the first dose of study drug. Received any anti-cancer or investigational therapy within 14 ...

8. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

   ... monoclonal antibody therapy; Palliative radiation therapy is permitted if clinically indicated and not indicative of progressive disease. Participating Mayo ...

9. Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies - Mayo Clinic

   Known intolerance to CD20 monoclonal antibody therapy. History of primary central nervous system (CNS) lymphoma or CNS neoplastic disease. Platelet count ...

10. A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma - Mayo Clinic

    ... monoclonal antibody and. B-cell maturation antigen (BCMA)-directed therapy - Cohort D: Newly diagnosed multiple myeloma per IMWG with a history of 4 to 8 ...